Remove 2002 Remove Clinical Trials Remove Edibles Remove Treatment
article thumbnail

Best strains and terpenes for focus and flow state

The Cannigma

A 2002 study found that cannabis increases blood flow to the frontal lobe of the brain. Oral delivery methods like tinctures and edibles have a longer effect time, while inhaled cannabis (like smoking or vaping) delivers results quickly, but also fades quickly. How you consume matters too.

Terpenes 122
article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

Scientists are hopeful that psychedelics might have more of a curative effect when it comes to mental health than many existing treatment options; meaning that unlike most psychiatric medications, psychedelics may be able to prompt long-term changes to our mental state with only a few doses. Are psychedelics safe?

History 123
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Lancet Neurol Dec 23 2015. Fabricio A.